Related Experiment Video
Updated: Jun 20, 2026

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
Cushing disease as possible cause of persistent growth failure despite growth hormone therapy in a small for
MaryKathleen Heneghan1, Ramin Alemzadeh
1Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI 53226-0509, USA.
Insights
Growth hormone therapy in children with small for gestational age (SGA) can unmask Cushing's disease. A case study shows GH therapy revealed Cushing's in a boy with short stature, leading to diagnosis and successful treatment.
Area of Science:
- Pediatric Endocrinology
- Endocrinology
- Metabolic Disorders
Background:
- Growth hormone (GH) therapy is beneficial for children with small for gestational age (SGA) and short stature.
- Early adrenarche, hypertension, and insulin resistance are potential complications.
- This case highlights a rare presentation in pediatric endocrinology.
Observation:
- An 11-year-old male with SGA and short stature developed early adrenarche, hypertension, and insulin resistance during GH therapy.
- The patient showed poor response to GH and insulin resistance symptoms, which partially responded to metformin.
- Persistent hypertension and elevated dehydroepiandrosterone sulfate prompted further investigation.
Findings:
- Elevated urinary free cortisol excretion indicated hypercortisolism.
- Inferior petrosal sinus sampling and pituitary MRI confirmed Cushing's disease.
- Partial adenohypophysectomy normalized cortisol levels and resolved associated symptoms.
Implications:
- Growth hormone therapy may unmask underlying Cushing's disease in susceptible children.
- Early diagnosis and treatment of Cushing's disease are crucial in pediatric patients.
- This case underscores the importance of vigilant monitoring for metabolic and endocrine complications during pediatric GH therapy.
Abstract:
Growth hormone (GH) therapy in children with small for gestational age (SGA) has been shown to be of significant therapeutic benefit. We report the case of an 11-year-old Caucasian male who developed early adrenarche, hypertension and insulin resistance on GH therapy for SGA and profound short stature (ht -5 SD). This patient demonstrated a poor response to GH therapy and developed physical and biochemical findings of insulin resistance responsive to metformin therapy. He remained hypertensive, however, and continued to have elevated serum dehydroepiandrosterone sulfate levels. Urinary free cortisol excretion was subsequently found to be elevated. The diagnosis of Cushing's disease was confirmed with inferior petrosal sinus sampling and pituitary MRI. The patient underwent partial adenohypophysectomy with resulting normalization of plasma cortisol levels and associated symptoms. Our patient's diagnosis of Cushing's disease was complicated by his past history of poor growth since birth and history of SGA. The signs of Cushing's disease did not overtly appear until GH therapy was initiated to help treat severe short stature. It is possible that the metabolic effects of GH therapy unmasked the presence of underlying Cushing's disease.
Related Concept Videos
Cushing Syndrome II: Pathophysiology
Cushing Syndrome I: Introduction
Nature and Nurture
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Hypoglycemia and Glucagon
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.
